Shypd.aiThe largest open index of AI tools
Abzu is a biotechnology company that applies explainable AI to develop best-in-class RNA therapies for major medical needs. It focuses on drug design, particularly for siRNA, ASO, and anti-miR therapeutics, and uses AI-guided design to accelerate R&D.
Trending
Also listed in
About
Abzu is a biotechnology company leveraging explainable AI to innovate in the field of RNA therapeutics. The company specializes in developing best-in-class RNA drugs, including siRNAs, ASOs, and anti-miRs, for significant medical needs. Their AI-guided design platform, powered by the QLattice®, allows for the in silico exploration and prioritization of vast sequence spaces, evaluating over 100,000 design variants to predict efficacy and developability properties. This approach significantly reduces experimental cycles, lowers costs, and shortens the time to candidate selection. Abzu also focuses on RNA-based delivery systems, developing targeted aptamers for cell-specific uptake of therapeutic RNA, offering a modular platform for precision delivery beyond the liver. The team combines deep RNA biology, AI-driven design, and drug development experience to create a closed learning loop where data refines models and models improve molecules.
Capabilities
Pricing & Plans
Enterprise · Custom · Likely Not Free
Not publicly disclosed. Check abzu.ai for current pricing.
FAQs
Trending
